TRCT
NRX

Tower Research Capital (TRC)’s NEPHROGENEX INC COM NRX Stock Holding History

Tower Research Capital (TRC)’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,179
Closed -$10K – 5626
2015
Q4 		$10K Buy
+6,179
New +$14.4K ﹤0.01% 2212
2015
Q3 		– Sell
-200
Closed -$1K – 5409
2015
Q2 		$1K Buy
200
+100
+100% +$760 ﹤0.01% 4207
2015
Q1 		$1K Buy
+100
New +$785 ﹤0.01% 4279
2014
Q4 		– Sell
-800
Closed -$4K – 5265
2014
Q3 		$4K Sell
800
-1,256
-61% -$5.98K ﹤0.01% 3531
2014
Q2 		$13K Sell
2,056
-199
-9% -$1.27K ﹤0.01% 2184
2014
Q1 		$18K Buy
+2,255
New +$23K ﹤0.01% 2037

Other funds holding NRX

RCP
Rho Capital Partners New York $20.4M AUM
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s NRX Position: Q1 2016 in Review

Tower Research Capital (TRC) sold out of NEPHROGENEX INC COM (NRX) in Q1 2016, closing a stake of 6,179 shares — an estimated $10K sold.

Tower Research Capital (TRC) first reported a position in NRX in Q1 2014 and held it in 6 quarters. The position peaked at $18K in Q1 2014. 17 funds tracked by Wall St. Rank hold NRX as of Q1 2016.

  • Tower Research Capital (TRC) reported no remaining NEPHROGENEX INC COM position as of Q1 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6,179 NEPHROGENEX INC COM shares in Q1 2016, an estimated $10K.
  • Tower Research Capital (TRC) first reported a position in NEPHROGENEX INC COM in Q1 2014 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s NEPHROGENEX INC COM position peaked at $18K in Q1 2014.
  • 17 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q1 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2016, filed 16 May 2016.